Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma

NCT01747876 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
32
Enrollment
INDUSTRY
Sponsor class

Stopped Lack of efficacy caused enrollment to be stopped at the end of dose escalation

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals